Verification of the IDI-MRSA assay for detecting methicillin-resistant Staphylococcus aureus in diverse specimen types in a core clinical laboratory setting.
The IDI-MRSA assay has a sensitivity of 96% and a specificity of 96% when used to screen patients at extranasal sites. This verification study used previously unverified swabs and was undertaken in a core medical laboratory using nonmicrobiology technologists trained in sample processing, molecular laboratory work flow, and PCR practice.
Drews
Steven J
SJ
Department of Laboratory Medicine, North York General Hospital, Toronto, Ontario M2K1E1, Canada.
Willey
Barbara M
BM
Kreiswirth
Nathan
N
Wang
Min
M
Ianes
Teresa
T
Mitchell
Jayne
J
Latchford
Mary
M
McGeer
Allison J
AJ
Katz
Kevin C
KC
D006801:Humans; D016106:Methicillin Resistance; D016133:Polymerase Chain Reaction / Q000379:methods*; D012680:Sensitivity and Specificity; D013203:Staphylococcal Infections / Q000382:microbiology*; D013211:Staphylococcus aureus / Q000187:drug effects* / Q000302:isolation & purification*